Neoteryx is focused on delivering simple, quantitative, and automatable microsampling solutions for biological samples which enable convenient sample collection anywhere, anytime, by anyone. Neoteryx customers do their work across the biological spectrum.
Four years of research and development coupled with a co-development program with major American and European pharmaceutical companies resulted in Neoteryx inventing the revolutionary Volumetric Absorptive Microsampling (VAMS™) technology. VAMS technology and relating intellectual property is currently used to develop and manufacture the Mitra® Microsampling Device portfolio, which is a suite of products for the collection, storage, and transport of blood and other biological fluids.
The Mitra device accurately and reliably collects 10 or 20 µL of blood (or other biological fluid) in seconds, while eliminating the volumetric hematocrit bias typically associated with the dried blood spotting technique. Once the sample is collected, the Mitra Microsampler is dried, stored, and transported under ambient conditions eliminating the need for laborious plasma processing steps and costly cold chain and medical courier transportation. To process samples an automatable extraction is performed with common solvents.
The CE/IVD and FDA Class 1 listed Mitra Microsampling Device, which is currently available in four formats. The 96-rack and 96-autorack are recommended for research, method development and semi-automated / automated sample extraction processing. The clamshell format, available with 2, 3 or 4 microsamplers, is an economical option for field sampling whereas the cartridge format is a more elegant solution for remote sampling as it includes barcodes for managing chain-of-custody as well as a re-sealable bag and desiccant for shipping samples. Neoteryx is continually expanding its portfolio of microsampling products to support their customers.
The Mitra Microsampler class I medical device is for direct specimen collection of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements.